Hydroxyurea for Malignant Pertussis in Critically Ill Children
Hydroxyurea is an alternative therapy for malignant pertussis infection that can efficiently address hyperleukocytosis with limited mortality.
Authors
- Pierre Tissières (ORCID: https://orcid.org/0000-0001-5423-5532)
- Vladimir L. Cousin (ORCID: https://orcid.org/0000-0001-5729-671X)
- Clémence Marais
- Matthieu Blanc
- Alexandre Debs
Institutions
- Centre National de la Recherche Scientifique (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Université Paris-Saclay (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Institut de Biologie Intégrative de la Cellule (FR)
- CEA Paris-Saclay (FR)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- Critical Care Explorations
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1097/cce.0000000000001218
- Citations
- 3
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.88
Funders
- Centre National de la Recherche Scientifique